Role of Annexin II tetramer in plasminogen activation

Trends in Cardiovascular Medicine

Volumn 9, Issue 3-4, 1999, Pages 92-102

  Kang, Hyoung Min ^a   Choi, Kyu Sil ^a   Kassam, Geetha ^a   Fitzpatrick, Sandra L ^a   Kwon, Mijung ^a   Waisman, David M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; LIPOCORTIN 2; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN[LYSINE];

ANGIOGENESIS; BINDING SITE; CELL SURFACE; ENDOTHELIUM CELL; HUMAN; KINETICS; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; VASCULAR ENDOTHELIUM;

ANIMALS; ANNEXIN A2; ENDOTHELIUM, VASCULAR; PLASMIN; PLASMINOGEN; RECEPTORS, CELL SURFACE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033117168     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(99)00012-2     Document Type: Review

References (62)

1. Becker T, Weber K, Johnsson N: 1990. Protein-protein recognition via short amphiphilic helices: A mutational analysis of the binding site of annexin II for p11. EMBO J 9:4207-4213.
2. Beebe DP, Miles LA, Plow EF: 1989. A linear amino acid sequence involved in the interaction of t-PA with its endothelial cell receptor. Blood 74:2034-2037.
3. Blasi F, Behrendt N, Cubellis MV, et al.: 1990. The urokinase receptor and regulation of cell surface plasminogen activation. Cell Differ Dev 32:247-253.
4. Blasi F, Verde P: 1990. Urokinase-dependent cell surface proteolysis and cancer. Semin Cancer Biol 1:117-126.
5. Borza DB, Morgan WT: 1997. Acceleration of plasminogen activation by tissue plasminogen activator on surface-bound histidine-proline-rich glycoprotein. J Biol Chem 272: 5718-5726.
6. Bu G, Warshawsky I, Schwartz AL: 1994. Cellular receptors for the plasminogen activators. Blood 83:3427-3436.
7. Carmeliet P, Collen D: 1996. Gene manipulation and transfer of the plasminogen and coagulation system in mice. Semin Thromb Hemost 22:525-542.
8. Cesarman GM, Guevara CA, Hajjar KA: 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA- dependent plasminogen activation. J Biol Chem 269:21,198-21,203.
9. Chavakis T, Kanse SM, Yutzy B, Lijnen HR, Preissner KT: 1998. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes. Blood 91:2305-2312.
10. Choi KS, Ghuman J, Kassam G, Kang HM, Fitzpatrick SL, Waisman DM: 1998. Annexin II tetramer inhibits plasmin-dependent fibrinolysis. Biochemistry 37:648-655.
11. Chung CY, Erickson HP: 1994. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol 126:539-548.
12. Chung CY, Murphy-Ullrich JE, Erickson HP: 1996. Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell 7:883-892.
13. Demange P, Voges D, Benz J, Liemann S, Gottig P, Berendes R, Burger A, Huber R: 1994. Annexin V: The key to understanding ion selectivity and voltage regulation? Trends Biochem Sci 19:272-276.
14. Drust DS, Creutz CE: 1988. Aggregation of chromaffin granules by calpactin at micro-molar levels of calcium. Nature 331:88-91.
15. Dudani AK, Ganz PR: 1996. Endothelial cell surface actin serves as a binding site for plasminogen, tissue plasminogen activator and lipoprotein(a). Br J Haematol 95:168-178.
16. Ellis V: 1996. Functional analysis of the cellular receptor for urokinase in plasminogen activation. J Biol Chem 271:14,779-14,784.
17. Ellis V, Behrendt N, Dano K: 1991. Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptor. J Biol Chem 266:12,752-12,758.
18. Favier-Perron B, Lewit-Bentley A, Russo-Marie F: 1996. The high-resolution crystal structure of human annexin III shows subtle differences with annexin V. Biochemistry 35:1740-1744.
19. Felez J, Miles LA, Fabregas P, Jardi M, Plow EF, Lijnen RH: 1996. Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells. Thromb Haemost 76:577-584.
20. Gerke V, Weber K: 1984. Identity of p36K phosphorylated upon rous sarcoma virus transformation with a protein purified from brush borders: Calcium-dependent binding to non-erythroid spectrin and F-actin. EMBO J 3:227-233.
21. Glenney JR Jr, Boudreau M, Galyean R, Hunter T, Tack B: 1986. Association of the S-100-related calpactin I light chain with the NH2-terminal tail of the 36-kDa heavy chain. J Biol Chem 261:10,485-10,488.
22. Gonzalez-Gronow M, Edelberg JM, Pizzo SV: 1989. Further characterization of the cellular plasminogen binding site: Evidence that plasminogen 2 and lipoprotein a compete for the same site. Biochemistry 28:2374-2377.
23. Hajjar KA: 1993. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest 91:2873-2879.
24. Hajjar KA: 1995. Cellular receptors in the regulation of plasmin generation. Thromb Haemost 74:294-301.
25. Hajjar KA, Guevara CA, Lev E, Dowling K, Chacko J: 1996. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface: Essential role of endonexin repeat. J Biol Chem 271:21,652-21,659.
26. Hajjar KA, Harpel PC, Jaffe EA, Nachman RL: 1986. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 261:11,656-11,662.
27. Hajjar KA, Jacovina AT, Chacko J: 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem 269:21,191-21,197.
28. Hajjar KA, Nachman RL: 1988. Endothelial cell-mediated conversion of glu-plasminogen to lys-plasminogen: Further evidence for assembly of the fibrinolytic system on the endothelial cell surface. J Clin Invest 82:1769-1778.
29. Hall SW, Humphries JE, Gonias SL: 1991. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin. J Biol Chem 266:12,329-12,336.
30. Hayes ML, Castellino FJ: 1979a. Carbohydrate of the human plasminogen variants. I. Carbohydrate composition, glycopeptide isolation, and characterization. J Biol Chem 254: 8768-8771.
31. Hayes ML, Castellino FJ: 1979b. Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit. J Biol Chem 254:8777-8780.
32. Hembrough TA, Li L, Gonias SL: 1996. Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J Biol Chem 271:25,684-25,691.
33. Henkin J, Marcotte P, Yang HC: 1991. The plasminogen-plasmin system. Prog Cardiovasc Dis 34:135-164.
34. Horrevoets AJ, Smilde A, de Vries C, Pannekoek H: 1994. The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis. J Biol Chem 269:12,639-12,644.
35. Horrevoets AG, Pannekoek H, Nesheim ME: 1997. Production and characterization of recombinant human plasminogen(S741C-fluorescein): A novel approach to study zymogen activation without generation of active protease. J Biol Chem 272:2176-2182.
36. Hubaishy I, Jones PG, Bjorge J, Bellagamba C, Fitzpatrick S, Fujita DJ, Waisman DM: 1995. Modulation of annexin II tetramer by tyrosine phosphorylation. Biochemistry 34:14,527-14,534.
37. Johnstone SA, Hubaishy I, Waisman DM: 1992. Phosphorylation of annexin II tetramer by protein kinase C inhibits aggregation of lipid vesicles by the protein. J Biol Chem 267:25,976-25,981.
38. 2+-dependent regulators of membrane function. News Physiol Sci 10:171-176.
39. Kanalas JJ, Makker SP: 1991. Identification of rat heymann nephritis autoantigen (GP330) as a receptor site for plasminogen. J Biol Chem 266:10825-10829.
40. Kang HM, Kassam G, Jarvis SE, Fitzpatrick SL, Waisman DM: 1997. Characterization of human recombinant annexin II tetramer purified from bacteria: Role of N-terminal acetylation. Biochemistry 36:2041-2050.
41. Kasai S, Arimura H, Nishida M, Suyama T: 1985. Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. J Biol Chem 260:12,377-12,381.
42. Kassam G, Choi KS, Ghuman J, et al.: 1998a. The role of annexin II tetramer in the activation of plasminogen. J Biol Chem 273:4790-4799.
43. Kassam G, Le BH, Choi KS, Kang HM, Fitzpatrick S, Louie P, Waisman DM: 1998b. The p11 subunit of annexin II tetramer plays a key role in the stimulation of t-PA- dependent plasminogen activation. Biochemistry 37:16,958-16,966.
44. Lijnen HR, Hoylaerts M, Collen D: 1980. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen: Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. J Biol Chem 255:10,214-10,222.
45. Longstaff C, Clough AM, Gaffney PJ: 1992. Kinetics of plasmin activation of single chain urinary-type plasminogen activator (scu-PA) and demonstration of a high affinity interaction between scu-PA and plasminogen . J Biol Chem 267:173-179.
46. Luecke H, Chang BT, Mailliard WS, Schlaepfer DD, Haigler HT: 1995. Crystal structure of the annexin XII hexamer and implications for bilayer insertion. Nature 378:512-515.
47. Miles LA, Dahlberg CM, Levin EG, Plow EF: 1989. Gangliosides interact directly with plasminogen and urokinase and may mediate binding of these fibrinolytic components to cells. Biochemistry 28:9337-9343.
48. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF: 1991. Role of cell-surface lysines in plasminogen binding to cells: Identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30:1682-1691.
49. Nakata T, Sobue K, Hirokawa N: 1990. Conformational change and localization of calpactin I complex involved in exocytosis as revealed by quick-freeze, deep-etch electron microscopy and immunocytochemistry. J Cell Biol 110:13-25.
50. Nilius B, Gerke V, Prenen J, et al.: 1996. Annexin II modulates volume-activated chloride currents in vascular endothelial cells. J Biol Chem 271:30,631-30,636.
51. Redlitz A, Plow EF: 1995. Receptors for plasminogen and t-PA: An update. Baillieres Clin Haematol 8:313-327.
52. Rijken DC, Hoylaerts M, Collen D: 1982. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 257:2920-2925.
53. Senda T, Okabe T, Matsuda M, Fujita H: 1994. Quick-freeze, deep-etch visualization of exocytosis in anterior pituitary secretory cells: Localization and possible roles of actin and annexin II. Cell Tiss Res 277:51-60.
54. Siever DA, Erickson HP: 1997. Extracellular annexin II. Int J Biochem Cell Biol 29:1219-1223.
55. Stack S, Gonzalez-Gronow M, Pizzo SV: 1990. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 29:4966-4970.
56. 2+-bridging mechanism and phospholipid head group recognition in the membrane-binding protein annexin V. Nature Struct Biol 2:968-974.
57. Swairjo MA, Seaton BA: 1994. Annexin structure and membrane interactions: A molecular perspective. Annu Rev Biophys Biomol Struct 23:193-213.
58. Thiel C, Osborn M, Gerke V: 1992. The tight association of the tyrosine kinase substrate annexin II with the submembranous cytoskeleton depends on intact p11- and Ca(2+)-binding sites. J Cell Sci 103:733-742.
59. Waisman DM: 1995. Annexin II tetramer: Structure and function. Mol Cell Biochem 149/150:301-322.
60. Winram SB, Lottenberg R: 1996. The plasmin-binding protein Plr of group A streptococci is identified as glyceraldehyde-3-phosphate dehydrogenase. Microbiology 142:2311-2320.
61. Wright JF, Kurosky A, Wasi S: 1994. An endothelial cell-surface form of annexin II binds human cytomegalovirus. Biochem Biophys Res Commun 198:983-989.
62. Yeatman TJ, Updyke TV, Kaetzel MA, Dedman JR, Nicolson GL: 1993. Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin Exp Metastasis 11:37-44.